EZZ Life Science Holdings (ASX:EZZ) has entered a manufacturing agreement with US-based GLSP, to produce nutritional supplements for the North American market, according to a Tuesday filing with the Australian bourse.
GLSP will manufacture EZZ-branded products in compliance with the US Food and Drug Administration regulations and under ISO standards, with third-party testing for microbiological and heavy metals safety, the filing added.
The agreement stipulates a production timeline of six to 10 weeks, starting from the receipt of all production requirements and the initial payment, while EZZ will retain full intellectual property rights, including patents and formulations.
Shares of the company fell 6% in recent Tuesday trade.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。